Moreover, there is now clear evidence that PV patients harbor both anti-Dsg3 antibodies that lead to blister formation (pathogenic) and anti-Dsg3 antibodies that do not lead to blister formation (nonpathogenic) [2], [11]. The gene discussed is DSG3; the disease is acquired polycythemia vera.